Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A KEITH

Showing results (741-750 of 918) with videos related to

Pageof 92
Sort By:
Journal of Fish Biology|July 30, 2019
Species richness and functional structure of fish assemblages in three freshwater habitats: effects of environmental factors and managementJamile Queiroz-Sousa, Sally A Keith, Gianmarco S David, et al.
British Journal of Haematology|February 17, 2015
Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myelomaJoseph R Mikhael, Craig B Reeder, Edward N Libby, et al.
Cancer Gene Therapy|September 23, 2003
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancerSuzane Trudel, John Trachtenberg, Ants Toi, et al.
Military Medicine|June 3, 2015
Evaluating the implementation and sustainability of a program for enhancing veterans' intimate relationshipsAlice G Fortune-Britt, Jason A Nieuwsma, Jennifer M Gierisch, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|October 18, 2019
Assessing ecological function in the context of species recoveryH Resit Akçakaya, Ana S L Rodrigues, David A Keith, et al.
Biology Letters|August 24, 2012
What is macroecology?Sally A Keith, Tom J Webb, Katrin Böhning-Gaese, et al.
Ejhaem|September 2, 2022
Transcriptional profiles define drug refractory disease in myelomaYuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, et al.
Cancer Research|May 6, 2004
Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivoYoung Trieu, Xiao-Yan Wen, Brian F Skinnider, et al.
Cancer|March 27, 2015
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myelomaRuth Seggewiss-Bernhardt, Ralf C Bargou, Yeow Tee Goh, et al.
Proceedings. Biological Sciences|May 13, 2016
Coral mass spawning predicted by rapid seasonal rise in ocean temperatureSally A Keith, Jeffrey A Maynard, Alasdair J Edwards, et al.
Pageof 92

Showing results (741-750 of 918) with videos related to

Sort By:
Pageof 92
Journal of Fish Biology|July 30, 2019
Species richness and functional structure of fish assemblages in three freshwater habitats: effects of environmental factors and managementJamile Queiroz-Sousa, Sally A Keith, Gianmarco S David, et al.
British Journal of Haematology|February 17, 2015
Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myelomaJoseph R Mikhael, Craig B Reeder, Edward N Libby, et al.
Cancer Gene Therapy|September 23, 2003
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancerSuzane Trudel, John Trachtenberg, Ants Toi, et al.
Military Medicine|June 3, 2015
Evaluating the implementation and sustainability of a program for enhancing veterans' intimate relationshipsAlice G Fortune-Britt, Jason A Nieuwsma, Jennifer M Gierisch, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|October 18, 2019
Assessing ecological function in the context of species recoveryH Resit Akçakaya, Ana S L Rodrigues, David A Keith, et al.
Biology Letters|August 24, 2012
What is macroecology?Sally A Keith, Tom J Webb, Katrin Böhning-Gaese, et al.
Ejhaem|September 2, 2022
Transcriptional profiles define drug refractory disease in myelomaYuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, et al.
Cancer Research|May 6, 2004
Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivoYoung Trieu, Xiao-Yan Wen, Brian F Skinnider, et al.
Cancer|March 27, 2015
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myelomaRuth Seggewiss-Bernhardt, Ralf C Bargou, Yeow Tee Goh, et al.
Proceedings. Biological Sciences|May 13, 2016
Coral mass spawning predicted by rapid seasonal rise in ocean temperatureSally A Keith, Jeffrey A Maynard, Alasdair J Edwards, et al.
Pageof 92